MNOVMediciNova, Inc.

$69M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$325,710

Balance Sheet

Total Assets

$69M

Total Liabilities

$4M

Stockholders' Equity

$65M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$4M	+19.3%
Net Income	-$3M	-$4M	+28.7%

MNOV Q2 2023 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena